Although the exact names of individual scientists involved in tirzepatides discovery are not always published, we know that a team of medical researchers, chemists, and pharmacologists at Eli Lilly worked together to study, test, and refine the drug over several years
This single-target approach has been refined over decades and remains highly effective for weight management
Ethics statement The study is considered exempt research by the United States Department of Health and Human Services under 45 CFR 46.104(d)(4) as it involved only the secondary use of data that were de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA), specifically, 45 CFR 164.514
Weight Loss Management & Medication Patients who are overweight or obese are at higher risk of developing chronic diseases such as diabetes, high blood pressure, heart disease, and some cancers